Tci Wealth Advisors, Inc. Amarin Corp Plcuk Transaction History

Tci Wealth Advisors, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 02, 2021	SELL	$4.26 - $6.5 $852 - $1,300	-200 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$5.03 - $8.8 $1,006 - $1,760	200 New	200 $1,000
Q4 2020 Jan 21, 2021	SELL	$4.04 - $5.31 $808 - $1,062	-200 Closed	0 $0
Q3 2020 Oct 20, 2020	SELL	$3.64 - $7.76 $2,548 - $5,432	-700 Reduced 77.78%	200 $1,000
Q2 2020 Jul 20, 2020	BUY	$4.78 - $8.26 $1,434 - $2,478	300 Added 50.0%	900 $6,000
Q1 2020 Apr 14, 2020	SELL	$4.0 - $21.53 $2,800 - $15,071	-700 Reduced 53.85%	600 $2,000
Q4 2019 Jan 27, 2020	BUY	$13.94 - $24.12 $1,394 - $2,412	100 Added 8.33%	1,300 $28,000
Q3 2019 Oct 17, 2019	BUY	$13.89 - $23.16 $1,389 - $2,316	100 Added 9.09%	1,200 $18,000
Q2 2019 Jul 23, 2019	BUY	$16.27 - $20.51 $6,508 - $8,204	400 Added 57.14%	1,100 $21,000
Q1 2019 Apr 11, 2019	BUY	$12.61 - $22.33 $1,261 - $2,233	100 Added 16.67%	700 $15,000
Q4 2018 Jan 17, 2019	BUY	$12.41 - $22.98 $7,446 - $13,788	600 New	600 $8,000

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $185M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.